Nexofen – Pulse Pharmaceuticals

Abandoned App ID 6171735 Class 5 Word

Trademark information

IP India · live record
Application ID
6171735
Status
Abandoned
Sub status
Not Applicable
Date of application
01 November 2023
Classes
5
Type
Word
Proprietor
Pulse Pharmaceuticals Private #18/1 Sector Iii, Huda Techno Enclave, Hitech City, Madhapur, Hyderabad 500081, Telangana State, India.
Agent
R. V. R Associates.[6457]Flat No. G 4, #. 3 4 543 & 544, Laxmi Nilayam, Adj: Ymca Ground Narayan Guda, Hyderabad 500027.
State
Telangana
Filing mode
e-Filing
IP office
Chennai
Used since
—
Valid / upto
—

Goods & services

Class 5

Class 5Medicinal and Pharmaceuticals Preparations and Substances. Dietetic food and substances adapted for medical or veterinary use, food for babies; Dietary supplements for human beings.

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 01 Nov 2023
2 Reply to Exam Report (MIS-R) 26 Dec 2023
3 TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) 22 Jul 2025
4 Documents in support of Show cause Hearing (SCH) 22 Jul 2025
5 Journal Copy 24 Apr 2026
6 TM-O(NOTICE OF OPPOSITION) 26 Jun 2026
7 TM-O(NOTICE OF OPPOSITION) 01 Jul 2026
8 TM-O(NOTICE OF OPPOSITION) 06 Jul 2026

Correspondence and notices

1 EXAMINATION REPORT 16697552 01 Dec 2023
2 Hearing Notice for Application No. 6171735 20304974 28 May 2025
3 Hearing Notice for Application No. 6171735 20846753 12 Sep 2025
4 Tribunal Accepted Notice for : 6171735 21892649 · 7664501 25 Feb 2026
5 Opposition Notice 23115262 · 7916359 03 Jul 2026
6 Opposition Notice 23115270 · 7916360 03 Jul 2026
7 Opposition Notice 23168894 · 7924776 08 Jul 2026
8 Order Form of 21(2) 24031529 · 8034070 21 Sep 2026
9 Order Form of 21(2) 24031530 · 8034071 21 Sep 2026
10 Order Form of 21(2) 24031531 · 8034072 21 Sep 2026

Frequently asked questions

Nexofen was applied for on 01 November 2023.

The application was filed by Pulse Pharmaceuticals.

Class 5.

As per IP India, the status is Abandoned.

The listed application ID of Nexofen is 6171735.

Trademark attorney R. V. R Associates.